Displaying drugs 876 - 900 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Edoxudine | 256.258 C11H16N2O5 |  | A deoxythymidine analog used to treat herpetic keratitis. | Antiviral Agents |
| Edrophonium | 166.2401 C10H16NO |  | A cholinesterase inhibitor used to diagnose and evaluate myasthenia gravis. | Antidotes / Cholinesterase Inhibitors / Phenylammonium Compounds / Quaternary Ammonium Compounds |
| Efavirenz | 315.675 C14H9ClF3NO2 |  | A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection or prevent the spread of HIV. | Cytochrome P-450 CYP2B6 Inducers / Non-Nucleoside Reverse Transcriptase Inhibitors |
| Efinaconazole | 348.398 C18H22F2N4O |  | An antifungal agent used to treat onychomycosis, a fungal infection of the nail. | Imidazole and Triazole Derivatives |
| Eflornithine | 182.171 C6H12F2N2O2 |  | An ornithine decarboxylase inhibitor used to prevent relapse of high-risk neuroblastoma in pediatric and adult patients | Antineoplastic Agents / Antiprotozoals / Decarboxylase Inhibitor / Ornithine Decarboxylase Inhibitors / Trypanocidal Agents |
| Elacestrant | 458.646 C30H38N2O2 |  | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. | Anti-Estrogens |
| Elafibranor | 384.49 C22H24O4S |  | A peroxisome proliferator-activated receptor agonist used to treat primary biliary cholangitis in adults with intolerance of inadequate response to ursodeoxycholic acid. | PPAR alpha, agonists / PPAR delta, agonists |
| Elagolix | 631.6 C32H30F5N3O5 |  | A gonadotropin releasing hormone receptor antagonist used to treat moderate to severe pain in endometriosis. | Anti-Gonadotropin-Releasing Hormones |
| Elbasvir | 882.035 C49H55N9O7 |  | An antiviral and NS5A inhibitor used to treat hepatitis C infections. | Antivirals for treatment of HCV infections |
| Eletriptan | 382.519 C22H26N2O2S |  | A triptan used for the treatment of migraines. | Selective Serotonin 5-HT1 Receptor Agonists / Serotonin Receptor Agonists |
| Elexacaftor | 597.66 C26H34F3N7O4S |  | A small molecule CFTR corrector used in combination with tezacaftor and ivacaftor for the treatment of cystic fibrosis patients with one F508del-CFTR mutation. | Cystic Fibrosis Transmembrane Conductance Regulator Correctors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Membrane Transport Modulators / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
| Eliglustat | 404.551 C23H36N2O4 |  | A glucosylceramide synthase used to treat type 1 Gaucher disease in patients who are CYP2D6 extensive, intermediate, or poor metabolizers. | Various Alimentary Tract and Metabolism Products |
| Eltrombopag | 442.4666 C25H22N4O4 |  | A thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies. | Thrombopoietin Receptor Agonist |
| Eluxadoline | 569.662 C32H35N5O5 |  | A mixed mu-opioid receptor agonist used to treat irritable bowel syndrome with diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Elvitegravir | 447.884 C23H23ClFNO5 |  | An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. | Anti-HIV Agents / Anti-Retroviral Agents / HIV Integrase / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / Integrase Inhibitors |
| Emedastine | 302.4145 C17H26N4O |  | A selective H1-receptor antagonist used topically to manage symptoms of allergic conjunctivitis. | Anti-Allergic Agents / Histamine H1 Antagonists / Histamine H1 Inhibitors |
| Empagliflozin | 450.91 C23H27ClO7 |  | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Emtricitabine | 247.247 C8H10FN3O3S |  | A nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV. | Anti-HIV Agents / Antiviral Agents / Deoxycytidine / Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor / Nucleoside and Nucleotide Reverse Transcriptase Inhibitors / Reverse Transcriptase Inhibitors |
| Enalapril | 376.4467 C20H28N2O5 |  | A prodrug of an ACE inhibitor used to treat hypertension and congestive heart failure. | ACE Inhibitors and Calcium Channel Blockers / ACE Inhibitors and Diuretics |
| Enalaprilat | 348.3936 C18H24N2O5 |  | An antihypertensive agent used for the management of hypertension when oral therapy is not practical. | Angiotensin-Converting Enzyme Inhibitors / Antihypertensive Agents / Antihypertensive Agents Indicated for Hypertension / Drugs causing inadvertant photosensitivity |
| Enasidenib | 473.383 C19H17F6N7O |  | An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. | Isocitrate Dehydrogenase 2 Inhibitor |
| Encainide | 352.4699 C22H28N2O2 |  | A voltage-gated sodium channel blocker used for management of atrial or ventricular fibrillation, atrial flutter, and ventricular tachycardia, that is no longer used due to proarrhythmic adverse effects. | Antiarrhythmic agents / Antiarrhythmics, Class Ic |
| Encorafenib | 540.01 C22H27ClFN7O4S |  | A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Enflurane | 184.492 C3H2ClF5O |  | A halogenated inhalational anesthetic agent used for the induction and maintenance of anesthesia and for analgesia during labor and delivery. | Anesthetics, General / Anesthetics, Inhalation / Methyl Ethers |
| Enmetazobactam | 314.32 C11H14N4O5S |  | A beta-lactamase inhibitor used to treat complicated urinary tract infections in combination with cefepime. | beta-Lactamase Inhibitors |
Displaying drugs 876 - 900 of 2785 in total